Skip to content

Celcuity CELC Shares (Diluted)

Shares (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
895.9M-0.5%
Gilead Sciences logo
Gilead SciencesGILD
1.3B-0.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
194.8M+2.4%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
162.2M+43.1%
CG Oncology logo
CG OncologyCGON
84.5M+10.9%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
96.1M+11.8%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's shares (diluted)?
Celcuity (CELC) reported shares (diluted) of 54.5M in Q1 2026.
How has Celcuity's shares (diluted) changed year-over-year?
Celcuity's shares (diluted) increased by 26.5% year-over-year, from 43.1M to 54.5M.
What is the long-term trend for Celcuity's shares (diluted)?
Over 3 years (2021 to 2025), Celcuity's shares (diluted) has grown at a 51.6% compound annual growth rate (CAGR), from 51.9M to 181.1M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.